Cloudy Peritoneal Effluent in a Stable CAPD Patient: Diagnose, Treat, and Decide About the Catheter
Ms. L is a 58-year-old woman receiving continuous ambulatory peritoneal dialysis for 3 years. She presents with 18 hours of diffuse abdominal pain, nausea, and a cloudy peritoneal effluent bag. Temperature 38.2°C, BP 132/78, HR 96. Exit site is clean without erythema or drainage. She had a dental cleaning 4 days ago without prophylactic antibiotics. Effluent cell count is 1,450/µL with 88% neutrophils; Gram stain shows gram-positive cocci in clusters. She has residual urine output of 400 mL/day and a history of MRSA nasal colonization. Her last peritonitis episode was 14 months ago and responded to intraperitoneal antibiotics. She has no history of abdominal surgery. Her serum creatinine is 8.2 mg/dL and potassium 4.6 mmol/L. She is hemodynamically stable and wants to know if the catheter must be removed today.
1. What is the diagnosis, and which specimens and tests should be obtained before the first antibiotic dose? Explain why each matters.
Read the worked answer
Diagnosis: PD-associated peritonitis. The combination of abdominal pain, cloudy effluent, fever, and effluent WBC 1,450/µL with 88% neutrophils meets the usual threshold (>100 WBC/µL with >50% neutrophils after an adequate dwell).
Before antibiotics: send effluent for cell count with differential, Gram stain, and culture. Culture should be inoculated into blood culture bottles or processed by a concentrated method to improve yield. A fungal culture is reasonable given prior antibiotic exposure or an atypical course. Blood cultures are indicated if she is systemically ill. Do not delay empiric antibiotics for hours waiting for culture collection; obtain the specimen and treat promptly. Imaging is not routinely needed unless there is an intra-abdominal source, ileus, or a refractory course. The Gram stain helps guide later therapy but should not be used alone to narrow initial coverage.
2. Select an empiric intraperitoneal antibiotic regimen and justify coverage. How do you dose and monitor in a patient with residual kidney function?
Read the worked answer
Empiric coverage: cover both gram-positive and gram-negative organisms. A standard approach is intraperitoneal vancomycin plus a third-generation cephalosporin such as ceftazidime or cefepime. Because she has MRSA nasal colonization, I would favor vancomycin rather than a first-generation cephalosporin for gram-positive coverage. If she were vomiting or septic, I would use IV therapy and consider admission.
Dosing: give a weight-based vancomycin loading dose in the peritoneal dwell and adjust subsequent doses by trough, targeting an intraperitoneal trough of at least 15 mg/L for peritonitis. Cefepime is commonly dosed as 1 g IP per exchange, with adjustment for residual renal function and local protocol. Her residual urine output of 400 mL/day contributes to drug clearance, so levels and clinical response matter more than a fixed schedule.
Monitoring: reassess clinically and check effluent WBC at 48–72 hours; narrow antibiotics once culture and susceptibility results return.
3. What findings at 48–72 hours would make you remove the catheter, and what should you reassess before removal?
Read the worked answer
Catheter removal criteria: no clinical improvement or persistent cloudy effluent at 48–72 hours, persistent fever, effluent WBC that is not falling, fungal peritonitis, refractory peritonitis (failure to clear by about 5 days), relapsing peritonitis, or tunnel/exit-site infection with abscess. Before removal, reassess adherence and exchange technique, repeat cultures, confirm adequate IP antibiotic dosing, and exclude intra-abdominal pathology or catheter malfunction. For uncomplicated peritonitis that is improving, the catheter should be salvaged. If removal is required, coordinate transfer to hemodialysis and plan reinsertion after recovery. The Gram stain alone is not a reason to remove the catheter.